Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease
University of British Columbia
$45,000.00
Bacteria and Mucus: A dysfunctional relationship leading to IBD
EF 2011-12
Résumé
Inflammatory bowel disease (IBD) is a group of illnesses, all characterized by persistent inflammation of the colon and small intestine. We still have only limited knowledge as to what triggers IBD, but recent research suggests the breakdown of mucus integrity may be a cause. Additionally, it is known that the intestinal microbiota has a significant ability to modulate the intestinal mucus layer, impacting both its composition and thickness. We hypothesize that defects in mucus function leads to exaggerated bacterial contact with the immune system, thereby worsening colitis.
In both IBD and the commonly used DSS colitis model, shifts in mucus thickness, composition, or glycosylation may render the mucus layer increasingly permeable to the resident bacteria of the gut. This allows them to associate too closely with the intestinal epithelium, stimulating MyD88 mediated toll-like receptors (TLRs) and other elements of the innate immune system, resulting in inflammation along the intestinal epithelium and impacting the ability of the host to control the mucus layer, and the intestinal microflora.
We propose to test this hypothesis with Muc2 KO and C3GnT KO mice deficient in Muc2, and mucin glycosylation. We will examine how these two models react when treated with 3% DSS to induce colitis, and how the mucus barrier is maintained under these circumstances. During these treatments, we will monitor the severity of the induced inflammation, and how the microflora begins to infiltrate the mucus layer over time. We expect that the loss of the outer mucus layer in the muc2 KO or mucin glycosylation in the C3GnT KO, we expect to see the mucus layer become more permeable to the intestinal microflora. We believe this mechanism to be similar to what occurs in IBD, where the mucus layer becomes more permeable, allowing the bacteria to become more closely associated with the intestinal epithelium, trigger inflammation.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
243168
Name
Stahl Martin
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Bacteria and Mucus: A dysfunctional relationship leading to IBD
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Dss Colitis; Ibd; Inflammation; Innate Immunity; Intestinal Epithelium; Intestinal Microflora; Mouse Models; Muc2; Mucus; Toll-Like-Receptors
Abstract
Inflammatory bowel disease (IBD) is a group of illnesses, all characterized by persistent inflammation of the colon and small intestine. We still have only limited knowledge as to what triggers IBD, but recent research suggests the breakdown of mucus integrity may be a cause. Additionally, it is known that the intestinal microbiota has a significant ability to modulate the intestinal mucus layer, impacting both its composition and thickness. We hypothesize that defects in mucus function leads to exaggerated bacterial contact with the immune system, thereby worsening colitis.
In both IBD and the commonly used DSS colitis model, shifts in mucus thickness, composition, or glycosylation may render the mucus layer increasingly permeable to the resident bacteria of the gut. This allows them to associate too closely with the intestinal epithelium, stimulating MyD88 mediated toll-like receptors (TLRs) and other elements of the innate immune system, resulting in inflammation along the intestinal epithelium and impacting the ability of the host to control the mucus layer, and the intestinal microflora.
We propose to test this hypothesis with Muc2 KO and C3GnT KO mice deficient in Muc2, and mucin glycosylation. We will examine how these two models react when treated with 3% DSS to induce colitis, and how the mucus barrier is maintained under these circumstances. During these treatments, we will monitor the severity of the induced inflammation, and how the microflora begins to infiltrate the mucus layer over time. We expect that the loss of the outer mucus layer in the muc2 KO or mucin glycosylation in the C3GnT KO, we expect to see the mucus layer become more permeable to the intestinal microflora. We believe this mechanism to be similar to what occurs in IBD, where the mucus layer becomes more permeable, allowing the bacteria to become more closely associated with the intestinal epithelium, trigger inflammation.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Stahl, Martin
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~